ANA MERCEDES CIUREA to Treatment Outcome
This is a "connection" page, showing publications ANA MERCEDES CIUREA has written about Treatment Outcome.
Connection Strength
0.012
-
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol. 2016 Apr; 50:79-89.
Score: 0.008
-
Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone. J Am Acad Dermatol. 2008 Jan; 58(1):60-2.
Score: 0.004